Pure Global: Brazil's Sudden MedTech Shift - Decoding ANVISA's New Equivalence Mandate.

This week on LATAM MedTech Insights, we dissect the seismic shift in Brazil's regulatory landscape. Last week, ANVISA issued an unexpected technical note on clinical evaluation requirements under RDC 751, fundamentally altering the path to market for many international device manufacturers. We explore the end of the 'easy' equivalence route based on CE or FDA clearance and what this means for your technical dossier, budget, and timeline. This isn't just a minor update; it's a strategic challenge that redefines market entry into Latin America's largest economy. Imagine you're a US-based orthopedic company, weeks away from submitting your dossier to ANVISA, only to find your entire clinical strategy, built on equivalence to your CE-marked device, is now invalid. We discuss the real-world scramble this has caused. In This Episode, We Uncover: 1. What specific clause in the new ANVISA note created this regulatory hurdle? 2. Why is relying on your existing CE mark or FDA 510(k) for equivalence in Brazil now a critical risk? 3. What are the three immediate strategic options for manufacturers affected by this change? 4. How does this shift impact the timeline and cost for new device registrations in Brazil? 5. Is it still possible to use the equivalence pathway, and if so, what is the new gold standard for a predicate device? 6. What does this move signal about ANVISA's long-term regulatory direction? 7. How can you proactively monitor for these kinds of 'surprise' updates from regulatory bodies? Navigating sudden regulatory shifts in LATAM requires more than just knowledge; it requires on-the-ground intelligence and a proactive strategy. At Pure Global, we offer end-to-end regulatory consulting for MedTech and IVD companies, leveraging local expertise and advanced AI tools to streamline global market access. Whether it's developing a new clinical strategy for Brazil or managing submissions across 30+ markets, we are your local representative. Don't let regulatory surprises derail your expansion. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to secure your market presence.